Relmada Therapeutics Inc
NASDAQ:RLMD

Watchlist Manager
Relmada Therapeutics Inc Logo
Relmada Therapeutics Inc
NASDAQ:RLMD
Watchlist
Price: 3.74 USD -1.58% Market Closed
Market Cap: 274.3m USD

Profitability Summary

Relmada Therapeutics Inc's profitability score is 41/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score
41/100
Profitability
Score

Margins

Earnings Waterfall
Relmada Therapeutics Inc

Margins Comparison
Relmada Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Relmada Therapeutics Inc
NASDAQ:RLMD
274.3m USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
218.3B GBP
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.7B CHF
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Relmada Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Relmada Therapeutics Inc
NASDAQ:RLMD
274.3m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
218.3B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.7B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Relmada Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate